Skip to content

Usefulness and safety of Mw vaccine versus Mantoux antigen in patients of warts caused by virus

A double blind, randomized controlled trial to compare the effectiveness and safety of Purified Protein Derivative (PPD) of Tuberculin Antigen with Mycobacterium w (Mw) vaccine in the treatment of multiple viral warts

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009327
Enrollment
64
Registered
2017-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Multiple viral warts

Interventions

Intervention1: Purified Protein Derivative (PPD): 0.1 ml PPD of strength 10TU/0.1ml administered intradermally into the volar aspect of forearm using an insulin syringe, at an interval of 2 weeks, for

Sponsors

Medical College Kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i.Male or female patients between 18 and 65 years of age (both inclusive). ii.Multiple viral warts >=5. iii.Patients who give their informed consent

Exclusion criteria

Exclusion criteria: i.Pregnant and lactating women. ii.Any evidence of immunosuppression (eg. HIV infection, organ transplantation, long term steroid use etc.). iii.Any other systemic disease (eg. liver or kidney disorder). iv.Presence of mucosal wart(s). v.Presence of ulcerated or inflamed wart(s). vi.Patients who participated in a clinical trial in the last three months

Design outcomes

Primary

MeasureTime frame
Number of wartsTimepoint: Baseline, 2, 4, 6, 8, 10, 14, 18, 22 weeks

Secondary

MeasureTime frame
Serum for Liver Function Test, urea, creatinine, Hemoglobin, Total count, Differential Count, Erythrocyte Sedimentation RateTimepoint: Screening visit, 10 weeks

Countries

India

Contacts

Public ContactSomodyuti Chandra

Department of Dermatology Medical College Kolkata

drdasnilay@gmail.com9433394148

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026